FY2025 EPS Estimates for Elevance Health Reduced by Analyst

Elevance Health, Inc. (NYSE:ELVFree Report) – Equities research analysts at Cantor Fitzgerald cut their FY2025 earnings per share estimates for shares of Elevance Health in a report released on Friday, January 24th. Cantor Fitzgerald analyst S. James now anticipates that the company will earn $34.57 per share for the year, down from their prior forecast of $34.65. Cantor Fitzgerald has a “Overweight” rating and a $485.00 price target on the stock. The consensus estimate for Elevance Health’s current full-year earnings is $32.95 per share.

Elevance Health (NYSE:ELVGet Free Report) last released its quarterly earnings data on Thursday, January 23rd. The company reported $3.84 earnings per share for the quarter, topping analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a net margin of 3.68% and a return on equity of 19.56%.

Several other analysts also recently weighed in on the company. Argus downgraded Elevance Health from a “buy” rating to a “hold” rating in a research note on Friday, October 18th. Stephens lowered Elevance Health from an “overweight” rating to an “equal weight” rating and lowered their price target for the company from $520.00 to $440.00 in a report on Wednesday, January 22nd. Raymond James set a $485.00 price objective on shares of Elevance Health in a report on Friday, October 18th. Wells Fargo & Company lowered their price objective on shares of Elevance Health from $483.00 to $478.00 and set an “overweight” rating on the stock in a research note on Tuesday. Finally, Truist Financial cut their target price on Elevance Health from $520.00 to $480.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Four analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $524.47.

Check Out Our Latest Research Report on ELV

Elevance Health Stock Performance

ELV opened at $405.67 on Monday. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.56. The business’s 50 day moving average is $386.42 and its 200-day moving average is $460.49. The stock has a market cap of $94.08 billion, a PE ratio of 14.79, a price-to-earnings-growth ratio of 1.11 and a beta of 0.84. Elevance Health has a twelve month low of $362.21 and a twelve month high of $567.26.

Institutional Investors Weigh In On Elevance Health

A number of large investors have recently made changes to their positions in the company. Raelipskie Partnership purchased a new position in Elevance Health during the 3rd quarter worth approximately $26,000. PSI Advisors LLC acquired a new stake in shares of Elevance Health in the third quarter worth $27,000. Eastern Bank purchased a new position in shares of Elevance Health during the third quarter valued at $31,000. Crews Bank & Trust acquired a new position in Elevance Health during the fourth quarter valued at $34,000. Finally, Dunhill Financial LLC lifted its stake in Elevance Health by 57.8% in the 3rd quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock worth $37,000 after acquiring an additional 26 shares in the last quarter. Institutional investors and hedge funds own 89.24% of the company’s stock.

Elevance Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Shareholders of record on Monday, March 10th will be issued a dividend of $1.71 per share. This represents a $6.84 annualized dividend and a yield of 1.69%. The ex-dividend date of this dividend is Monday, March 10th. This is an increase from Elevance Health’s previous quarterly dividend of $1.63. Elevance Health’s payout ratio is presently 23.77%.

About Elevance Health

(Get Free Report)

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.

Featured Articles

Earnings History and Estimates for Elevance Health (NYSE:ELV)

Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.